R.A. Session II's Net Worth
Estimate Recalculated Apr 10, 2025 08:15PM EST
Who is R.A. Session II
R.A. Session II has an estimated net worth of $18.4 Million. This is based on reported shares across multiple companies, which include Taysha Gene Therapies, Inc., AveXis, Inc., and Chardan Healthcare Acquisition 2 Corp..
SEC CIK
R.A. Session II's CIK is 0001701846
Past Insider Trading and Trends
2021 was R.A. Session II's most active year for acquiring shares with 3 total transactions. R.A. Session II's most active month to acquire stocks was the month of February. 2023 was R.A. Session II's most active year for disposing of shares, totalling 7 transactions. R.A. Session II's most active month to dispose stocks was the month of April. 2021 saw R.A. Session II paying a total of $529,102.40 for 242,218 shares, this is the most they've acquired in one year. In 2023 R.A. Session II cashed out on 748,595 shares for a total of $388,733.84, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
